Breakthrough Mucormycosis Developing on Mucorales-Active Antifungals Portrays a Poor Prognosis in Patients with Hematologic Cancer

Although breakthrough mucormycosis (BT-MCR) is known to develop on mold-active antifungals without Mucorales activity, it can also occur while on Mucorales-active antifungals. Herein, we retrospectively compared the characteristics and outcomes of patients with hematologic malignancies (HMs) or hema...

Полное описание

Библиографические подробности

Главные авторы:	Dierdre B. Axell-House, Sebastian Wurster, Ying Jiang, Andreas Kyvernitakis, Russell E. Lewis, Jeffrey J. Tarrand, Issam I. Raad, Dimitrios P. Kontoyiannis
Формат:	Artigo
Язык:	Inglês
Опубликовано:	MDPI AG 2021-03-01
Серии:	Journal of Fungi
Предметы:	mucormycosis mortality antifungal therapy breakthrough mold infection hematologic malignancy
Online-ссылка:	https://www.mdpi.com/2309-608X/7/3/217
Метки:	Добавить метку Нет меток, Требуется 1-ая метка записи!